MGX

Metagenomi Therapeutics Inc. Common Stock (MGX)

Stock · NASDAQ · Health Care

$1.19as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$1.19
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Metagenomi Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • MGX
    Metagenomi Therapeutics Inc. Common Stock
    $1.2
    ▼ 0.83%
    Market cap $45.55MP/E
  • TVGN
    Tevogen Inc. Common Stock
    $6.89
    ▲ 2.07%
    Market cap $45.04MP/E
    $3.64$49.5
  • EXOZ
    eXoZymes Inc. Common Stock
    $7.17
    ▼ 0.10%
    Market cap $47.57MP/E
    $4.35$18.4
  • TIL
    Instil Bio Inc. Common Stock
    $7.58
    ▼ 3.56%
    Market cap $48.97MP/E
    $5.67$33.83
  • DYAI
    Dyadic International Inc. Common Stock
    $0.6207
    ▼ 3.02%
    Market cap $38.63MP/E
    $0.6197$1.6
  • ELUT
    Elutia Inc. Class A Common Stock
    $0.885
    ▲ 0.57%
    Market cap $38.32MP/E 0.75
    $0.5$2.4
  • INKT
    MiNK Therapeutics Inc. Common Stock
    $11.43
    ▼ 2.16%
    Market cap $53.26MP/E
    $8.48$16.98

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
6.28M
Total value held
$8.39M
Institutional holders
45
Top holders this quarter
  • Unknown1.06M
  • Unknown787.9K
  • Unknown529.0K
  • Unknown516.8K
  • Unknown496.8K
  • Unknown395.8K
  • Unknown382.2K
  • Unknown358.2K
  • Unknown264.4K
  • Unknown230.1K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.